Liu L - Search Results

1

Reliability and validity of the Chinese version of the Head and Neck Information Needs Questionnaire for patients with head and neck cancer and their caregivers.

Li Y, Liu L, Yan R, Su C, Guo H, Li X, Yue S. Li Y, et al. Among authors: liu l. Int J Nurs Sci. 2021 Jun 6;8(3):354-360. doi: 10.1016/j.ijnss.2021.06.004. eCollection 2021 Jul 10. Int J Nurs Sci. 2021. PMID: 34307786 Free PMC article.

2

Prevalence and determinants of depression in caregivers of cancer patients: A systematic review and meta-analysis.

Geng HM, Chuang DM, Yang F, Yang Y, Liu WM, Liu LH, Tian HM. Geng HM, et al. Medicine (Baltimore). 2018 Sep;97(39):e11863. doi: 10.1097/MD.0000000000011863. Medicine (Baltimore). 2018. PMID: 30278483 Free PMC article. Review.

3

Dignity at the end of life in traditional Chinese culture: Perspectives of advanced cancer patients and family members.

Liu L, Ma L, Chen Z, Geng H, Xi L, McClement S, Guo Q. Liu L, et al. Eur J Oncol Nurs. 2021 Oct;54:102017. doi: 10.1016/j.ejon.2021.102017. Epub 2021 Aug 14. Eur J Oncol Nurs. 2021. PMID: 34487967

4

Effect of the solution-focused brief therapy on cancer-related fatigue in breast cancer patients under adjuvant chemotherapy: a randomized trial.

Liu W, Geng H, Ma L, Liu F, Wei X, Tian X, Liu L. Liu W, et al. Among authors: liu l, liu f. Transl Cancer Res. 2020 Dec;9(12):7405-7414. doi: 10.21037/tcr-20-2734. Transl Cancer Res. 2020. PMID: 35117341 Free PMC article.

5

Tumor immune microenvironment in epidermal growth factor receptor-mutated non-small cell lung cancer before and after epidermal growth factor receptor tyrosine kinase inhibitor treatment: a narrative review.

Liu L, Wang C, Li S, Bai H, Wang J. Liu L, et al. Transl Lung Cancer Res. 2021 Sep;10(9):3823-3839. doi: 10.21037/tlcr-21-572. Transl Lung Cancer Res. 2021. PMID: 34733631 Free PMC article. Review.

6

Surgical and Conservative Management of Malignant Bowel Obstruction: Outcome and Prognostic Factors.

Yu K, Liu L, Zhang X, Zhang Z, Rao B, Chen Y, Li S, Shi H. Yu K, et al. Among authors: liu l. Cancer Manag Res. 2020 Aug 24;12:7797-7803. doi: 10.2147/CMAR.S256219. eCollection 2020. Cancer Manag Res. 2020. PMID: 32922079 Free PMC article.

7

ERO1L Is a Novel and Potential Biomarker in Lung Adenocarcinoma and Shapes the Immune-Suppressive Tumor Microenvironment.

Liu L, Wang C, Li S, Qu Y, Xue P, Ma Z, Zhang X, Bai H, Wang J. Liu L, et al. Front Immunol. 2021 Jul 20;12:677169. doi: 10.3389/fimmu.2021.677169. eCollection 2021. Front Immunol. 2021. PMID: 34354701 Free PMC article.

8

Predictive Value of Max's Giant Associated Protein Mutation in Outcomes of Lung Adenocarcinoma Patients Treated With Immune Checkpoint Inhibitors.

Qu Y, Wang C, Liu L, Li S, Zhang X, Ma Z, Bai H, Wang J. Qu Y, et al. Among authors: liu l. Front Cell Dev Biol. 2021 Oct 18;9:728647. doi: 10.3389/fcell.2021.728647. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 34733843 Free PMC article.

9

Comparative proteomic profiling of plasma exosomes in lung cancer cases of liver and brain metastasis.

Li S, Qu Y, Liu L, Zhang X, He Y, Wang C, Guo Y, Yuan L, Ma Z, Bai H, Wang J. Li S, et al. Among authors: liu l. Cell Biosci. 2023 Sep 28;13(1):180. doi: 10.1186/s13578-023-01112-5. Cell Biosci. 2023. PMID: 37770976 Free PMC article.

10

Efficacy and safety of treatment modalities across EGFR selected/unselected populations with non-small cell lung cancer and brain metastases: A systematic review and Bayesian network meta-analysis.

Liu L, Bai H, Seery S, Li S, Wang C, Xue P, Zhao J, Wang J. Liu L, et al. Lung Cancer. 2021 Aug;158:74-84. doi: 10.1016/j.lungcan.2021.02.031. Epub 2021 Feb 27. Lung Cancer. 2021. PMID: 34126551

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

74,427 results

Search Page

Filters